Etoposide Market Analysis by Type (Etoposide for Injection, Etoposide for Oral Use), by Application (Lung cancer, Testicular cancer, Ovarian cancer, Others), by Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies, Direct distribution) and by Region: Global Forecast, 2024 - 2034
- PUBLISHED ON
- 2024-04-19
- NO OF PAGES
- 231
- CATEGORY
- Healthcare & Life Sciences
Market Overview
The Etoposide market is predicted to develop at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2034, when it is projected to reach USD 1.97 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 0.87 Billion in 2024.
Â
SOURCE: We Market Research
Etoposide is a
member of the class of medications known as topoisomerase inhibitors and is one
chemotherapy treatment used to treat cancer. These enzymes, which specifically
target topoisomerase II, are necessary for DNA replication in rapidly dividing
cancer cells. Etoposide slows the growth of cancer by inhibiting these enzymes,
which stops DNA synthesis and results in cell death. Among other tumors, it is
used for lymphomas, testicular, and lung malignancies. Etoposide is
administered intravenously or orally as capsules. Although it works well, there
are side effects include nausea, hair loss, and bone marrow suppression. To
manage these adverse effects and get the best possible treatment results,
medical supervision is required. Etoposide is still a useful treatment in oncology
for a variety of cancers.
The rising incidence of cancer worldwide, particularly in developing nations, is one of the factors driving the global market for etoposide drugs. The fact that etoposide is an essential chemotherapy drug for the treatment of cancer greatly propels the market's expansion. Demand is further increased by developments in oncology research, such as etoposide-containing combination treatments. The need for chemotherapy medications like etoposide is fueled by the aging population, which is more common in industrialized areas and raises the incidence of cancer. Expanding markets are also supported by improvements in infrastructure and better access to healthcare in developing nations. All in all, these variables foster an atmosphere that is favorable to the continued expansion of the worldwide market for etoposide medications used to treat different forms of cancer.Â
Market Scope
|
Report Attributes |
Description |
|
Market Size in 2024 |
USD 0.87 Billion |
|
Market Forecast in 2034 |
USD 1.97Billion |
|
CAGR % 2024-2034 |
5.9% |
|
Base Year |
2023 |
|
Historic Data |
2016-2022 |
|
Forecast Period |
2024-2034 |
|
Report USP Â |
Production, Consumption, company share, company
heatmap, company production capacity, growth factors and more |
|
Segments Covered |
by Type, by Application, by Distribution Channel and By Region |
|
Regional Scope |
North America, Europe, APAC, South America and
Middle East and Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic
Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia;
Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa;
Nigeria |
Â
Etoposide Industry: Dynamics & Restrains
We Market Research: Etoposide Dashboard
Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.
Etoposide Segmentation
Market- By Type Analysis
By Type, the Etoposide Market is Categories into Etoposide for Injection, Etoposide for Oral Use. The Etoposide for Injection segment accounts for the largest share of around 72% in 2024.
Etoposide for Injection's market domination
is largely due to its extensive use in cancer treatments, where intravenous administration
enables accurate dosage delivery and efficient disease management.
The
following segments are part of an in-depth analysis of the global Etoposide
market:
|
Market Segments |
 |
|
By  Application |
·       Â
Lung cancer ·       Â
Testicular cancer ·       Â
Ovarian cancer ·       Â
Others |
|
By  Distribution
Channel |
·       Â
Hospital pharmacies ·       Â
Retail pharmacies ·       Â
Online pharmacies ·       Â
Direct distribution |
Â
Etoposide Industry: Regional Analysis
North America Market Forecast
North America dominate the Etoposide Market with the highest revenue generating market with share of more than 47%. The increased incidence of cancer cases, the sophisticated healthcare system, and the focus on oncology research and development are the main drivers of the etoposide market. Positive reimbursement guidelines and heightened knowledge of cancer therapy alternatives further support market expansion.
Europe Market Statistics
Europe has a
robust healthcare system and substantial investments in cancer research.
Increasing incidence of cancer and rising adoption of novel therapies support
the growth of the etoposide market in this region.
Asia Pacific Market Forecasts
Asia Pacific is
expected to be the fastest-growing regional segment of the Etoposide market
during the forecast period. The Asia Pacific region is witnessing robust market
expansion because of a substantial patient population, developing medical
facilities, and rising public awareness of cancer detection and treatment.
Government initiatives to improve cancer treatment and growing disposable
income are other factors driving industry growth.
Key Market PlayersÂ
The Etoposide Market is dominated by a few large
companies, such as
·       Â
Shyndec Pharmaceutical
·       Â
Qilu Antibiotics
·       Â
Gansu Fuzheng
·       Â
KPC Pharmaceuticals
·       Â
Nippon Kayaku
·       Â
Accord Healthcare
·       Â
Teva Pharmaceutical
·       Â
Mylan
·        Shyndec Pharmaceutical
·         Other
1.    Â
Global
Etoposide Market Introduction and Market Overview
1.1.   Objectives of the Study
1.2.   Global Etoposide Market Scope
and Market Estimation
1.2.1. Global Etoposide Overall Market
Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)
1.2.2. Global Etoposide Market Revenue
Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034
1.3.   Market Segmentation
1.3.1. Component of Global Etoposide
Market
1.3.2. Technology of Global Etoposide
Market
1.3.3. Distribution Channel  of Global Etoposide Market
1.3.4. Region of Global Etoposide
Market
2.    Â
Executive Summary
2.1.   Global Etoposide Market Industry Trends under COVID-19 Outbreak
2.1.1. Global COVID-19 Status Overview
2.1.2. Influence of COVID-19 Outbreak
on Global Etoposide Market
Industry Development
2.2.   Market Dynamics
2.2.1. Drivers
2.2.2. Limitations
2.2.3. Opportunities
2.2.4. Impact Analysis of Drivers and
Restraints
2.3.   Pricing Trends Analysis &
Average Selling Prices (ASPs)
2.4.   Key Mergers & Acquisitions,
Expansions, JVs, Funding / VCs, etc.
2.5.   Porter’s Five Forces Analysis
2.5.1. Bargaining Power of Suppliers
2.5.2. Bargaining Power of Buyers
2.5.3. Threat of Substitutes
2.5.4. Threat of New Entrants
2.5.5. Competitive Rivalry
2.6.   Value Chain / Ecosystem Analysis
2.7.   Russia-Ukraine War Impacts
Analysis
2.8.   Economic Downturn Analysis
2.9.     Market Investment Opportunity
Analysis (Top Investment Pockets), By Segments & By Region
3.    Â
Global Etoposide Market Estimates & Historical Trend Analysis (2019 -
2023)
4.    Â
Global Etoposide Market Estimates & Forecast Trend Analysis, by
TYPE
4.1.   Global Etoposide Market Revenue
(US$ Mn) Estimates and Forecasts, by TYPE, 2019 to 2034
4.1.1. Etoposide for Injection
4.1.2. Etoposide for Oral Use
5.    Â
Global Etoposide Market Estimates & Forecast Trend Analysis, by
Application
5.1.   Global Etoposide Market Revenue
(US$ Mn) Estimates and Forecasts, by Application, 2019 to 2034
5.1.1. Lung cancer
5.1.2. Testicular cancer
5.1.3. Ovarian cancer
5.1.4. Others
6.    Â
Global Etoposide Market Estimates & Forecast Trend Analysis, by
Distribution Channel
6.1.   Global Etoposide Market Revenue
(US$ Mn) Estimates and Forecasts, by Distribution
Channel, 2019 to 2034
6.1.1. Hospital pharmacies
6.1.2. Retail pharmacies
6.1.3. Online pharmacies
6.1.4. Direct distribution
7.    Â
Global Etoposide Market Estimates & Forecast Trend Analysis,
by Region
7.1.   Global Etoposide Market Revenue
(US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034
7.1.1. North America
7.1.2. Europe
7.1.3. Asia Pacific
7.1.4. Middle East & Africa
7.1.5. South America
8.    Â
North
America Etoposide Market: Estimates & Forecast Trend Analysis
8.1.  Â
North
America Etoposide Market Assessments & Key Findings
8.1.1. North America Etoposide Market
Introduction
8.1.2. North America Etoposide Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
8.1.2.1.  By TYPE
8.1.2.2.  By Application
8.1.2.3.  By Distribution
Channel
8.1.2.4.  By Country
8.1.2.4.1.    The U.S.
8.1.2.4.2.    Canada
8.1.2.4.3.    Mexico
9.    Â
Europe
Etoposide Market: Estimates & Forecast Trend Analysis
9.1.   Europe Etoposide Market
Assessments & Key Findings
9.1.1. Europe Etoposide Market
Introduction
9.1.2. Europe Etoposide Market Size
Estimates and Forecast (US$ Million) (2019 – 2034)
9.1.2.1.  By TYPE
9.1.2.2.  By Application
9.1.2.3.  By Distribution
Channel
9.1.2.4.      Â
By
Country
9.1.2.4.1.    Germany
9.1.2.4.2.    U.K.
9.1.2.4.3.    France
9.1.2.4.4.    Italy
9.1.2.4.5.    Spain
9.1.2.4.6.    Russia
9.1.2.4.7.    Rest of Europe
10. Asia Pacific Etoposide
Market: Estimates & Forecast Trend
Analysis
10.1. Asia Pacific Market Assessments
& Key Findings
10.1.1.  Asia Pacific Etoposide Market
Introduction
10.1.2.  Asia Pacific Etoposide Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
10.1.2.1.   By TYPE
10.1.2.2.   By Application
10.1.2.3.   By Distribution
Channel
10.1.2.4.   By Country
10.1.2.4.1. China
10.1.2.4.2. Japan
10.1.2.4.3. India
10.1.2.4.4. Australia
10.1.2.4.5. South Korea
10.1.2.4.6. ASEAN
10.1.2.4.7. Rest of Asia Pacific
11. Middle East & Africa Etoposide
Market: Estimates & Forecast Trend
Analysis
11.1. Middle East & Africa Market
Assessments & Key Findings
11.1.1.  Middle
East & Africa Etoposide
Market Introduction
11.1.2.  Middle
East & Africa Etoposide
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
11.1.2.1.   By TYPE
11.1.2.2.   By Application
11.1.2.3.   By Distribution
Channel
11.1.2.4.   By Country
11.1.2.4.1. U.A.E.
11.1.2.4.2. Saudi Arabia
11.1.2.4.3. Egypt
11.1.2.4.4. South Africa
11.1.2.4.5. Rest of Middle East & Africa
12. South America
Etoposide Market: Estimates &
Forecast Trend Analysis
12.1. South America Market Assessments
& Key Findings
12.1.1.  South America Etoposide Market
Introduction
12.1.2.  South America Etoposide Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
12.1.2.1.   By TYPE
12.1.2.2.   By Application
12.1.2.3.   By Distribution
Channel
12.1.2.4.   By Country
12.1.2.4.1. Brazil
12.1.2.4.2. Argentina
12.1.2.4.3. Colombia
12.1.2.4.4. Rest of South America
13. Competition Landscape
13.1. Global Etoposide Market
Competition Matrix & Benchmarking, by Leading Players / Innovators /
Emerging Players / New Entrants
13.2. Global Etoposide Market
Competition White Space Analysis, By Distribution Channel
13.3. Global Etoposide Market
Competition Heat Map Analysis, By Distribution Channel
13.4. Global Etoposide Market
Concentration & Company Market Shares (%) Analysis, 2022
14. Company Profiles
14.1.                   Â
Shyndec Pharmaceutical
14.1.1.  Company Overview & Key Stats
14.1.2.  Financial Performance & KPIs
14.1.3.  Product Portfolio
14.1.4.  Business Strategy & Recent
Developments
* Similar details would be provided
for all the players mentioned belowÂ
14.2.     Qilu
Antibiotics
14.3.     Gansu Fuzheng
14.4.     KPC
Pharmaceuticals
14.5.     Nippon Kayaku
14.6.     Accord
Healthcare
14.7.     Teva
Pharmaceutical
14.8.     Mylan
14.9.     Others
15. Research
Methodology
15.1. External Transportations /
Databases
15.2. Internal Proprietary Database
15.3. Primary Research
15.4. Secondary Research
15.5. Assumptions
15.6. Limitations
15.7. Report FAQs
16. Research Findings & Conclusion
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Frequently Asked Questions
What is the market size of Etoposide Market in 2024?
Etoposide Market was valued at USD 0.87 Billion in 2024.
What is the growth rate for the Etoposide Market?
Etoposide Market size will increase at approximate CAGR of 5.9% during the forecasted period.
Which are the top companies operating within the market?
Major companies operating within the Etoposide Market Are Shyndec Pharmaceutical, Qilu Antibiotics, Gansu Fuzheng, KPC Pharmaceuticals, China Resources Double Crane Pharmaceutical, Nippon Kayaku, Accord Healthcare, Teva Pharmaceutical, Mylan, Shyndec Pharmaceutical and Others.
Which region dominates the Etoposide Market?
North America dominates the market with an active share of 47%.
}})
Select a license type that suits your business needs
US $3750
Only Three Thousand Seven Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4750
Only Four Thousand Seven Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5750
Only Five Thousand Seven Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI